Aristotle Capital Boston LLC Sells 80,546 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

Aristotle Capital Boston LLC trimmed its position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 11.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 648,772 shares of the company's stock after selling 80,546 shares during the period. Aristotle Capital Boston LLC owned 1.31% of Nu Skin Enterprises worth $4,470,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Susquehanna International Group LLP increased its stake in Nu Skin Enterprises by 191.9% in the 4th quarter. Susquehanna International Group LLP now owns 702,127 shares of the company's stock worth $4,838,000 after purchasing an additional 461,608 shares during the period. JPMorgan Chase & Co. raised its stake in shares of Nu Skin Enterprises by 74.9% during the fourth quarter. JPMorgan Chase & Co. now owns 405,667 shares of the company's stock valued at $2,795,000 after acquiring an additional 173,710 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Nu Skin Enterprises by 18.5% in the fourth quarter. Bank of New York Mellon Corp now owns 613,330 shares of the company's stock worth $4,226,000 after purchasing an additional 95,938 shares during the last quarter. American Century Companies Inc. increased its holdings in Nu Skin Enterprises by 12.0% during the 4th quarter. American Century Companies Inc. now owns 824,739 shares of the company's stock valued at $5,682,000 after purchasing an additional 88,181 shares during the period. Finally, AlphaQuest LLC lifted its holdings in Nu Skin Enterprises by 197.8% in the 4th quarter. AlphaQuest LLC now owns 108,204 shares of the company's stock worth $746,000 after buying an additional 71,864 shares during the period. Institutional investors own 82.84% of the company's stock.

Nu Skin Enterprises Stock Up 15.9 %

Shares of NYSE:NUS traded up $0.98 during trading on Friday, hitting $7.14. The stock had a trading volume of 586,942 shares, compared to its average volume of 837,251. The company has a market capitalization of $355.02 million, a PE ratio of -2.42 and a beta of 0.92. The company has a quick ratio of 1.17, a current ratio of 1.82 and a debt-to-equity ratio of 0.56. The firm's fifty day moving average is $6.74 and its 200 day moving average is $6.93. Nu Skin Enterprises, Inc. has a 12 month low of $5.32 and a 12 month high of $14.00.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. The business had revenue of $364.49 million during the quarter, compared to the consensus estimate of $352.06 million. Analysts anticipate that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th were paid a $0.06 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $0.24 annualized dividend and a dividend yield of 3.36%. Nu Skin Enterprises's dividend payout ratio is presently -8.14%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Nu Skin Enterprises from a "buy" rating to a "hold" rating in a report on Tuesday, April 8th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.